increased circulating tyrosine level_Fah<tm1Mgo>/Fah<tm1Mgo>,Hgd<aku>/Hgd<+>

http://metadb.riken.jp/0013723I129S7SvEvBrdNBFahtm1MgoFahtm1MgoHgdakuHgdHgdakuFahtm1MgoHgd

increased circulating tyrosine level_Fah<tm1Mgo>/Fah<tm1Mgo>,Hgd<aku>/Hgd<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• homogentisate 1, 2-dioxygenase
  http://metadb.riken.jp/db/mgi_rdf/MGI:96078
• fumarylacetoacetate hydrolase
  http://metadb.riken.jp/db/mgi_rdf/MGI:95482

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fah<tm1Mgo>/Fah<tm1Mgo>,Hgd<aku>/Hgd<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Hgd<aku>|Fah<tm1Mgo>|Hgd<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd * NB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• http://purl.obolibrary.org/obo/MP_0013723

文献

http://purl.org/net/cito/citesAsAuthority

• K. Manning, et.al., In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I., Proceedings of the National Academy of Sciences of the United States of America, 1999, 96
  http://rdf.ncbi.nlm.nih.gov/pubmed/10518553